drugset / Trial / NCT06490991
Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The study is designed as a single-center, randomized, open-label, cross-over phase I clinical trial with the intention of recruiting 16 healthy subjects.
Timeline
- Start
- 2024-07-17
- Primary completion
- 2024-08-06
- Completion
- 2024-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-5965 | Small molecule | — | — |